Capital Expenditures - Cuu Long Pharmaceutical JSC (VN:DCL) - Alpha Spread
C

Cuu Long Pharmaceutical JSC
VN:DCL

Watchlist Manager
Cuu Long Pharmaceutical JSC
VN:DCL
Watchlist
Price: 25 100 VND -2.14%
Market Cap: 1.8T VND
Have any thoughts about
Cuu Long Pharmaceutical JSC?
Write Note

Cuu Long Pharmaceutical JSC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cuu Long Pharmaceutical JSC
Capital Expenditures Peer Comparison

Comparables:
H
DHT
I
IMP
D
DMC
D
DHG
T
TRA

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
C
Cuu Long Pharmaceutical JSC
VN:DCL
Capital Expenditures
-â‚«222.9B
CAGR 3-Years
-30%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
H
HaTay Pharmaceutical JSC
VN:DHT
Capital Expenditures
-â‚«287.1B
CAGR 3-Years
-24%
CAGR 5-Years
-45%
CAGR 10-Years
-44%
I
Imexpharm Corp
VN:IMP
Capital Expenditures
-â‚«83.7B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
-14%
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Capital Expenditures
-â‚«9.1B
CAGR 3-Years
-8%
CAGR 5-Years
28%
CAGR 10-Years
14%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Capital Expenditures
-â‚«319.1B
CAGR 3-Years
-70%
CAGR 5-Years
-49%
CAGR 10-Years
3%
T
Traphaco JSC
VN:TRA
Capital Expenditures
-â‚«101.3B
CAGR 3-Years
-25%
CAGR 5-Years
-21%
CAGR 10-Years
-10%

See Also

What is Cuu Long Pharmaceutical JSC's Capital Expenditures?
Capital Expenditures
-222.9B VND

Based on the financial report for Dec 31, 2023, Cuu Long Pharmaceutical JSC's Capital Expenditures amounts to -222.9B VND.

What is Cuu Long Pharmaceutical JSC's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-17%

Over the last year, the Capital Expenditures growth was 4%. The average annual Capital Expenditures growth rates for Cuu Long Pharmaceutical JSC have been -30% over the past three years , -17% over the past five years .

Back to Top